🇺🇸 FDA
Patent

US 6559137

Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors

expired A61PA61P31/12A61P31/18

Quick answer

US patent 6559137 (Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon May 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue May 06 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
41
CPC classes
A61P, A61P31/12, A61P31/18, A61P43/00